PCV22 COST-EFFECTIVENESS ANALYSIS OF OLMESARTAN/AMLODIPINE FIX-DOSE COMBINATION FOR HYPERTENSIVE PATIENTS IN CHINA
May 1, 2019, 00:00
10.1016/j.jval.2019.04.458
https://www.valueinhealthjournal.com/article/S1098-3015(19)30650-3/fulltext
Title :
PCV22 COST-EFFECTIVENESS ANALYSIS OF OLMESARTAN/AMLODIPINE FIX-DOSE COMBINATION FOR HYPERTENSIVE PATIENTS IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30650-3&doi=10.1016/j.jval.2019.04.458
First page :
Section Title :
Open access? :
No
Section Order :
10103